baber/WOPTO huggingface dataset:
Patent DE-69212838-D1 (DE)
Inventor: FERGUSON FREDERICK D
IPC: B64B1/58
Filed: 1992-09-09
Granted: 1996-09-19
Abstract: An airship in the form of a self-powered, elongated dirigible which comprises at least three sections connected together by joints. The sections including a front section with propulsion devices and control surfaces, at least one intermediate section designed to carry a payload and a rear section with control surfaces. The joints allow limited articulation between sections under gust conditions and tend to return the sections to aligned condition in calm air. A cover may provide a streamline exterior shape for the airship; alternatively the sections may have rims which mate together when there is no articulation to provide a smooth exterior shape.
Patent DE-69221686-D1 (DE)
Inventor: ABAD RAFAEL
IPC: A61K35/618
Filed: 1992-02-28
Granted: 1997-09-25
Abstract: An active ingredient for a therapeutic or cosmetic composition is obtained from live gastropoda (e.g., snails) which are physically stimulated (e.g., by centrifuging) to cause secretion of a fluid which is then centrifuged and filtered. Preferably the gastropoda are fasted prior to the physical stimulation. The therapeutic or cosmetic compositions contain about 0.1-30% of the active ingredient which is a mixture of amino acids and atoxic substances, an effective amount of an excipient preferred for use with biologically active ingredients, and other conventional ingredients provided they do not affect the stability and/or the activity. The therapeutic composition, in the form of a topical cream, can be used to treat various types of burns, dermatitis, eczema, diaper rash, and difficult to heal wounds. It can also be used to prevent skin cancer and radiodermatitis. The cosmetic composition can be used as hand and face creams, an anti-wrinkle cream, a sunscreen cream, a moisturizing lotion, and a deodorant.
Patent DE-69223565-D1 (DE)
Inventor: PAEZ BORRALLO JOSE MANUEL
IPC: H04M9/08
Filed: 1992-08-26
Granted: 1998-01-29
Abstract: Applicable to adaptive filtering of broadband acoustic signals, the objective being to eliminate problems of acoustic echoes. The method includes an additional stage for the generation of an inhibition vector (22) associated with the different segments of the filter that is fed with information from the activity monitoring stage (19) of the transmission and reception lines. The generation of the inhibition vector (22) takes into account the presence or lack of double-talking, implementing an adaption strategy that establishes the sections of the filter to be updated in each iteration. The calculation of the adaption step, independent for each uninhibited filter segment in the iteration in process, takes into account the local spectral characteristics of the voice signal and includes a new computational strategy. The device implements the different phases and stages of the method. The invention presents the advantages to increase the rate of convergence of the algorithm regardless of the incoming signal spectral characteristics, to improve the performance of the echo canceller, and to use a single digital signal processor. <IMAGE>
Patent DE-69229911-D1 (DE)
Inventor: ZAMARRON CONCEPCION
IPC: C07K14/75
Filed: 1992-02-12
Granted: 1999-10-07
Abstract: Receptor-induced binding sites (RIBS) expressed in a ligand when that ligand is bound in a complex with a receptor are disclosed, as are polypeptides that correspond in amino acid residue sequence with a RIBS expressed by a receptor-ligand complex. Particularly-preferred polypeptides correspond to a RIBS amino acid sequence of the gamma chain of human fibrinogen. Monoclonal antibodies that immunoreact with a RIBS but do not substantially immunoreact with either the ligand or the receptor when free in solution are also disclosed, as are hybridomas secreting those antibodies, and methods of making and using such antibodies.
Patent DE-69233605-D1 (DE)
Inventor: VALENTINE WILLIAM
IPC: A61K31/715
Filed: 1992-12-04
Granted: 2006-05-04
Abstract: A defoaming or antifoaming composition comprises a free flowing granular combinate of 50 to 90 weight percent of a water soluble carbohydrate-based agglomerate selected from the group consisting of maltodextrin agglomerates, maltodextrin/dextrose co-agglomerates, dextrose agglomerates, maltodextrin/sucrose co-agglomerates, maltodextrin/fructose co-agglomerates, sucrose agglomerates, fructose agglomerates, mannitol agglomerates, sorbitol agglomerates, agglomerates of hydrolyzed cereal solids, and agglomerates of corn syrup solids and about 10 to 50 weight percent of a liquid, nonaqueous, defoaming or antifoaming composition such as simethicone, hydrocarbon-based oils or silicone oils. The composition may be combined with one or more suitable excipients and prepared as a unit dosage in the form of a compressed tablet, filled capsule, packet, or granule for various defoaming applications.
Patent DE-69315446-D1 (DE)
Inventor: WRIGHT JAMES
IPC: C05F17/00
Filed: 1993-10-19
Granted: 1998-01-08
Abstract: A continuous composter comprises a train of composting in an elongate enclosed tunnel. The trays run on tracks above the level of the base of the tunnel. Garbage enters at one end of the tunnel and compost is removed from the other end. A ram shunts the trays stepwise through the tunnel. The tracks may be U-channels the webs of which are connected to tunnel side walls. The trays rest on one of the U and the other leg of the U extends over the edge of the tray to protect it from being fouled by garbage. Computer control may adjust proportions of aerating gas with recycled gas.
Patent DE-69317037-D1 (DE)
Inventor: PAGE PETER
IPC: H04L29/06
Filed: 1993-10-29
Granted: 1998-03-26
Abstract: An object interface is disclosed that supports three modes of inter-object communication -- message processing (store and forward), conversational communication, and remote procedure call. A service broker manages service requests from, and responsive services provided by, a plurality of clients and servers, respectively, which may reside on different hardware platforms and operating systems and may be connected to computer networks having different network architectures and associated communications protocols. The broker manages the service offerings from servers and service requests from clients, and clients and servers communicate and exchange information with one another via the broker. The service broker includes different application programming interfaces for allowing participants to access the functionality of the service broker. <IMAGE>
Patent DE-69323412-D1 (DE)
Inventor: MURNICK DANIEL E
IPC: B28B11/04
Filed: 1993-11-11
Granted: 1999-03-18
Abstract: A surface of a ceramic article, such as a glazed surface on a whiteware article, is treated with radiant energy such as infrared light from a laser to provide a localized remelting of the material at the surface in a fusing step. After the fusing step, the surface is treated with further radiant energy, desirably over a larger surface encompassing the fused zone and also desirably at a lower power density so as to limit the rate of cooling of the fusion zone and the immediately surrounding regions, thereby preventing thermal stress cracking. The fusion zone and surrounding regions desirably are preheated by additional radiant energy immediately prior to the fusing step so as to further limit thermal stresses during the fusing step. The process can be employed, among many other uses, for repair of glaze defects and for decoration. <IMAGE>
Patent DE-69323428-D1 (DE)
Inventor: PERSSON CHRISTIANE
IPC: A61K9/52
Filed: 1993-07-28
Granted: 1999-03-18
Abstract: The present invention concerns an oral morphine preparation having essentially complete bioavailability and, for the major part of the dissolution, an essentially zero order and essentially pH independent release of morphine for a period of at least 8 hours, preferably at least 12 hours, during which a period less than 100% is dissolved. In the preparation, the morphine, in the form of an easily soluble salt, is present in a combination with a buffering agent in a preparation coated with a diffusion membrane.
Patent DE-69323759-D1 (DE)
Inventor: ITOH JUNPEI
IPC: A61K31/56
Filed: 1993-10-26
Granted: 1999-04-08
Abstract: Products containing a nonsteroidal anti-estrogen or a pharmaceutically acceptable salt thereof and a glucocorticoid are disclosed as a combined preparation for concomitant use in treatment of auto-immune diseases. <IMAGE>
Patent DE-69326805-D1 (DE)
Inventor: HAMERSMA JOHANNES ANTONIUS MAR
IPC: A01N43/80
Filed: 1993-07-26
Granted: 1999-11-25
Abstract: The invention relates to a steroid derivative which steroidal skeleton is bound at carbon atom 17 to a spiromethylene ring of the formula: <CHEM> wherein Ra and Rb are independently selected from the group consisting of hydrogen, methyl, and halogen; m is 1 or 2; and the asterisk denotes carbon atom 2 of the spiromethylene ring which is carbon atom 17 (or carbon atom 17 alpha  of a homosteroid skeleton) of the steroid. The steroids have progestational or antiprogestational activity.
Patent DE-69328254-D1 (DE)
Inventor: SCARFONE A
IPC: A61M25/06
Filed: 1993-09-22
Granted: 2000-05-04
Abstract: A thoracentesis sheath catheter assembly includes a catheter connected to a valve body. The valve body is provided with a throughbore coaxial to the catheter for receiving a thoracentesis needle therethrough and a drainage bore in fluid communication with the first throughbore. The valve body is constructed as a first cylindrical portion which is connected to the catheter and a second cylindrical portion of larger inner diameter which is joined to the first cylindrical portion by a tapered inner wall. The second cylindrical portion contains a valve comprising a blocking ball and a spring biased plunger having a throughbore coaxial to the catheter, and is closed with a cap having a central hole and/or a gasket for sealingly receiving the thoracentesis needle. A thoracentesis needle extends through the hole of the cap, the gasket, the plunger, the first cylindrical portion and into and through the catheter. With the thoracentesis needle in place, communication between the throughbore and the drainage bore is blocked and a flow path is established through the needle. When the needle is removed, the throughbore is automatically obstructed by movement of the ball by the plunger along the tapered inner wall. However, a second fluid path is automatically established from the throughbore to the drainage bore.
Patent DE-69332939-D1 (DE)
Inventor: STROPPOLO FEDERICO
IPC: A61K31/765
Filed: 1993-01-11
Granted: 2003-06-12
Abstract: An ophthalmic pharmaceutical composition containing an association of N-acetyl-cysteine and polyvinylalcohol useful for the treatment of keratoconjunctivitis sicca.
Patent DE-69334174-D1 (DE)
Inventor: ISHIGURO TOSHIHIRO
IPC: C12N1/20
Filed: 1993-11-25
Granted: 2007-11-08
Abstract: A process for producing a saccharide carboxylic acid or a salt thereof is characterised in that a microorganism belonging to the genus Pseudogluconobacter and capable of oxidizing a hydroxymethyl group and/or hemiacetal hydroxyl-associated carbon atom to a carboxyl group, or an artefact derived from the microorganism, is permitted to act on a hydroxymethyl and/or hemiacetal hydroxyl-containing saccharide or saccharide derivative to produce and accumulate the corresponding carboxylic acid, and the carboxylic acid so accumulated is harvested; novel saccharide carboxylic acids produced by the above production method, and by the process, from a broad range of saccharides, saccharic acids having carboxyl groups derived from hydroxymethyl and/or hemiacetal OH groups can be produced with high selectivity and in good yield; the resultant saccharide acids are resistant to enzymatic degradation and have improved water solubility, among other characteristics.
Patent DE-69334240-D1 (DE)
Inventor: ELLIS FRANK B JR
IPC: G02F1/15
Filed: 1993-12-22
Granted: 2008-09-25
Abstract: Electrochromic devices (100, 110, 120, 130, 140, 150) are disclosed which may be used for large surface area applications. The devices utilize optical tuning layers (60, 61, 62, 63, 64, 65) to minimize optical interference between layers of the structure and to maximize uniform optical transparency. Optical tuning also enables transparent conductive oxide layers (20, 22) to be replaced by thin conductive metal layers (21, 23), thereby reducing the overall thickness of these devices and facilitating the manufacturing process. <IMAGE>
Patent DE-69428576-D1 (DE)
Inventor: KIMURA ISAO
IPC: C09D11/38
Filed: 1994-11-24
Granted: 2001-11-15
Abstract: Disclosed herein is a water-based ink composition comprising coloring material particles obtained by causing a dye to be adsorbed on or bonded to fine particles or an inorganic colloidal substance, and an aqueous solution of a water-soluble polymer dispersing the coloring material particles therein, wherein the polymer chains of the polymer in the composition undergo dissociation or association by its temperature change or pH change. <IMAGE>
Patent DE-69434297-D1 (DE)
Inventor: HODGES THOMAS K
IPC: C12N15/82
Filed: 1994-01-27
Granted: 2005-04-21
Abstract: A method of using a unique DNA construct for the creation of transgenic eukaryotic cells is described. The method allows a more precise and effective transformation procedure that targets the insertion of a DNA sequence into a predetermined DNA locus, while enabling the removal of any randomly inserted DNA sequences that occur as a by product of known transformation procedures.
Patent DE-69434332-D1 (DE)
Inventor: GIBBS CRAIG S
IPC: A61P35/00
Filed: 1994-11-14
Granted: 2005-05-19
Abstract: Novel polypeptides (NPs) are provided which are capable of protein C activation without significant fibrinogen clotting activity, and vice versa. NPs having enhanced protein C activating properties in relation to fibrinogen clotting are useful in particular as anticoagulants and in screening for substances that agonize or antagonize this property and in diagnostic procedures to determine the status of patients' activated protein C-mediated anticoagulant pathway. Procoagulant NPs are useful to promote clotting in the course of therapy of solid tumors, as an impregnate for bandages, or in diagnostic assays. The NPs are produced in recombinant cell culture or by in vitro methods.
Patent DE-69508216-D1 (DE)
Inventor: HOISINGTON PAUL A
IPC: B41J2/14
Filed: 1995-06-20
Granted: 1999-04-15
Abstract: In the high-frequency drop-on-demand ink jet system described in the specification, a variable impedance characteristic of an ink jet orifice is utilized to provide maximum drop ejection rates exceeding the maximum rates possible with constant orifice impedance characteristics. In one embodiment, successive negative, positive and negative pulses are applied to eject each drop in order to utilize a nonlinear orifice impedance characteristic, permitting maximum ink drop ejection rates exceeding 10-20 kHz and up to 150-200 kHz, and, in another embodiment, the ink jet orifice is designed with a bellmouth shape arranged to enhance the variable impedance characteristic.\!
Patent DE-69509076-D1 (DE)
Inventor: BALOGH GABOR
IPC: C05F3/00
Filed: 1995-12-08
Granted: 1999-05-20
Abstract: The subject of the invention is a process for producing compost of high water absorbing and retaining capacity, particularly by using compost material produced from wood industrial waste material which improves the soil fertility. During the process of the invention process the compost of wood industry origin transformed to plant absorbable manure and decomposed under aerobic conditions known per se to a water content of 30 to 35 %, sieving and putting the dehydrated product in prism while adding 1.5 to 3.0 % by weight water absorbing and retaining adjuvant is added to the compost during the prism formation process, turning over the prism several times by power machine, homogenising the mixture and covering with a black foil, its water content controlled and maintained at 30 to 35 % and, if desired, adjusting the water content within the above level. The process of the invention is used in agriculture.
Patent DE-69512996-D1 (DE)
Inventor: WILLIAMS CHARLES F
IPC: C09D7/80
Filed: 1995-11-21
Granted: 1999-12-02
Abstract: A method for the reduction or elimination of foam in a powder slurry coating composition. The method includes the steps of forming a powder slurry coating composition and adding a water soluble acid or water soluble compound having an acid functionality, to adjust the pH of the slurry to between 4 and 7.
Patent DE-69518572-D1 (DE)
Inventor: BONNET ANDRE
IPC: H05B41/282
Filed: 1995-04-05
Granted: 2000-10-05
Abstract: The resonant static convertor is of the ZVS type, and includes a mono-switch at the primary and a rectifier at the secondary. It includes at least one transformer (Tr), an output filter formed by a capacitor (Cs), and an additional circuit consisting of either a rectifier-doubler, or a load circuit. The converter may be extended by the provision of two transformers, and the output filtering may be provided by two capacitors in series.   <IMAGE>
Patent DE-69524757-D1 (DE)
Inventor: JOHNSON C
IPC: A61F2/82
Filed: 1995-06-30
Granted: 2002-01-31
Abstract: A dilator formed with a truss with a pair of spaced-apart end surfaces that provides a restoring force therebetween if forced toward one another, this restoring force provided by a resilient band extending between the opposite ends of the truss with a plurality of notches at each end thereof. The notches exceed at least a third of the thickness of the band. A second and similar band may also be provided in the truss.
Patent DE-69529566-D1 (DE)
Inventor: STRICKLIN K
IPC: F16L37/12
Filed: 1995-05-09
Granted: 2003-03-13
Abstract: A two-part coupling structure includes a male coupling part and a female coupling part which are mutually engageable to open fluid communication between a fluid-storage vessel and a conduit. The coupling parts are disengageable from one another to discontinue fluid communication between the vessel and the conduit, and also to close communication between ambient and each of the vessel and conduit. The retention volume of fluid which is trapped between the connected male and female coupling parts and which is exposed to or lost to ambient when the coupling parts are disconnected is very small. Because of particular structural features, the coupling parts will function reliably even with fluid having chunks or particulates of non-fluid material therein.
Patent DE-69531311-D1 (DE)
Inventor: FOUNDS W
IPC: G01N33/564
Filed: 1995-12-29
Granted: 2003-08-21
Abstract: The present invention relates to monoclonal antibodies to advanced glycosylation endproducts formed in vivo and cross-reactive with advanced glycosylation endproducts formed in vitro, and to methods of diagnosis and therapy based thereon. More particularly, the invention is directed to a monoclonal antibody, or an antigen-binding fragment thereof, reactive with in vivo produced advanced glycosylation endproducts (AGEs), which monoclonal antibody or antigen binding fragment thereof demonstrates an immunological binding characteristic of monoclonal antibody 4G9 as produced by hybridoma 4G9, deposited with the American Type Culture Collection (ATCC) and assigned Accession Number CRL 11626, on Apr. 27, 1994. In a specific embodiment, the 4G9 antibody is used in a sandwich ELISA to detect ApoB-AGE, IgG-AGE, collagen-AGE, serum-AGE peptides and proteins and urinary-AGE peptides and proteins.
Patent DE-69534744-D1 (DE)
Inventor: KRAMER CARY
IPC: C07K14/325
Filed: 1995-05-30
Granted: 2006-04-06
Abstract: The present invention is drawn to a novel toxin gene purified and isolated from Bacillus thuringiensis var kurstaki and given the designation CryIE(c). The novel toxin gene encodes a protein of approximately 130 kDa in size and is active against Lepidopteran insects. Also included in the invention are the proteins encoded by CryIE(c). Further disclosed are recombinant genes and proteins derived from CryIE(c). Also provided are biologically pure bacterial strains transformed with the CryIE(c) gene which can be used in entomocidal formulations for the control of Lepidopteran insects. Yet another aspect of the invention are plants transformed with the toxin gene or active fragments thereof, particularly where the transforming sequences have been optimized for expression in maize.
Patent DE-69604196-D1 (DE)
Inventor: CUVELIER MICHEL
IPC: G01S13/931
Filed: 1996-11-04
Granted: 1999-10-14
Abstract: A device for improving vehicle driving safety and comfort is disclosed. The main road sign information encountered during a journey is transmitted to the vehicle, the position of the vehicle on the driving surface is continuously monitored, and the road surface is checked for the presence of foreign matter such as mud, snow, ice, etc. A set of transmitting-receiving sensors (C1, C2) suitably arranged on the vehicle and facing the driving surface continuously observes changes in the reflective properties of the observed areas within the sensitivity range thereof. Markings defining lanes and shoulders lined with grassy, gravelly or sandy areas are sensed by the sensors (C1, C2) as soon as the vehicle approaches or drives over them. The signals from the sensors (C1, C2) are processed by an electronic unit (1) controlling an on-board signalling system (2) linked to an alarm system (3) for warning the driver of road hazards and possible unsafe driving (straying off-course, speeding, etc.). By reacting instantly, the driver thus informed can avoid a potential accident.
Patent DE-69607622-D1 (DE)
Inventor: BABIAK A
IPC: C07C227/12
Filed: 1996-07-12
Granted: 2000-05-11
Abstract: The present invention relates to a novel process for the preparation of ethyl 3S-[[4-[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-4-pentynoate and pharmaceutically acceptable acid addition salt thereof which comprises treating (trimethylsilyl)acetylene sequentially with n-butyllithium and 4-formylmorpholine followed by acid hydrolysis to give 3-(trimethylsilyl)-2-propynal; treating 3-(trimethylsilyl)-2-propynal with lithium bis(trimethylsilyl)amide to give in situ N,3-bis(trimethylsilyl)-2-propyn-1-imine; condensation of N,3-bis(trimethylsilyl)-2-propyn-1-imine with lithium t-butyl acetate to give (+/-)1,1-dimethylethyl 3-amino-5-(trimethylsilyl)-4-pentynoate; treating (+/-)1,1-dimethylethyl 3-amino-5-(trimethylsilyl)-4-pentynoate- with p-toluenesulfonic acid to give (+/-)1,1-dimethylethyl 3-amino-5-(trimethylsilyl)-4-pentynoate, mono p-toluenesulfonic acid salt, treatment of resulting salt with ethanol in the presence of p-toluenesulfonic acid to give (+/-)ethyl 3-amino-5-(trimethylsilyl)-4-pentynoate; desilylation of (+/-)ethyl 3-amino-5-(trimethylsilyl)-4-pentynoate to give in situ (+/-)ethyl 3-amino-4-pentynoate; resolution of (+/-)ethyl 3-amino-4-pentynoate using (R)-(-)-mandelic acid and treatment of the resolved product with gaseous hydrochloric acid to give ethyl 3S-amino-4-pentynoate, monohydrochloride; coupling the ethyl 3S-amino-4-pentynoate, monohydrochloride to 4-[[4-(aminoiminomethyl)phenyl]amino]-4-oxobutanoic acid, monohydrochloride in the presence of isobutyl chloroformate and N-methylmorpholine to give ethyl 3S-[[4-[[4-(aminoiminomethyl)phenyl]amino]-1,4-dioxobutyl]amino]-4-pentynoate, monohydrochloride.